Sign Up to like & get
recommendations!
0
Published in 2017 at "Annals of Hematology"
DOI: 10.1007/s00277-017-2928-7
Abstract: Dear Editor, We report the case of a 67-year-old male patient, suffering from progressing chronic lymphocytic leukemia (CLL) and treated with the tyrosine kinase inhibitor (TKI) duvelisib for 6 months, who was admitted for severe…
read more here.
Keywords:
patient treated;
lymphocytic leukemia;
treated duvelisib;
hypophysitis ... See more keywords